Drug profile · INN
perphenazine
PERPHENAZINE
perphenazine (PERPHENAZINE) is a dopamine d2 receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — perphenazine
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
perphenazine (PERPHENAZINE) is a dopamine d2 receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine D2 receptor antagonist
Primary target: D(2) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is perphenazine?
perphenazine (PERPHENAZINE) is a dopamine d2 receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for perphenazine?
PERPHENAZINE is a marketed brand name for perphenazine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of perphenazine?
perphenazine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.